Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases
- 4 September 2003
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 38 (3) , 234-239
- https://doi.org/10.1002/gcc.10275
Abstract
Translocations involving the immunoglobulin heavy‐chain genes are frequent in multiple myeloma (MM), which can be separated into two groups according to the chromosome number pattern. 14q32 translocations 14q32t are more frequent in hypodiploid than in hyperdiploid karyotypes. However, conventional cytogenetics (CC) misses cryptic translocations, especially t(4;14)(p16;q32). Furthermore, recent interphase fluorescence in situ hybridization (FISH) studies found 14q32t in as many as 75% of MM cases. To identify in which CC group we failed to detect translocations, we designed a study by use of FISH with a dual‐color IGH probe on previously R‐banded metaphase cells, allowing the detection of both 14q32t and overall chromosomal abnormalities, in a new series of 55 MM with abnormal karyotypes: 4/29 hyperdiploid (14%) and 19/26 hypodiploid (73%) cases had a 14q32t. The t(4;14) was found in 2 hyperdiploid (7%) and 10 hypodiploid (39%) cases. We therefore confirm that 14q32t are much more frequent in hypodiploid than in hyperdiploid MM (P < 0.0001) and that cryptic t(4;14)(p16;q32) is strongly associated with hypodiploid karyotypes (P < 0.01). Through the use of this reliable assay, only 42% of MM had 14q32t.Keywords
This publication has 23 references indexed in Scilit:
- Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapyBlood, 2002
- Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patientsBlood, 2002
- Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentationBlood, 2002
- Hypodiploidy is a major prognostic factor in multiple myelomaBlood, 2001
- The t(4;14)(p16.3;q32) is strongly associated with chromosome 13 abnormalities in both multiple myeloma and monoclonal gammopathy of undetermined significanceBlood, 2001
- Insertional events as well as translocations may arise during aberrant immunoglobulin switch recombination in a patient with multiple myelomaBritish Journal of Haematology, 2001
- Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myelomaNature Genetics, 1997
- Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3Nature Genetics, 1997
- Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myelomaProceedings of the National Academy of Sciences, 1996
- Cytogenetic study in multiple myeloma at diagnosis: comparison of two techniquesBritish Journal of Haematology, 1995